ロード中...
Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment
BACKGROUND: Smoking is one of well known environmental factors causing endothelial dysfunction and plays important role in the atherosclerosis. We investigated the effect of cilostazol could improve the endothelial dysfunction in smokers with the measurement of flow-mediated dilatation (FMD). METHOD...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Society of Echocardiography
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3079080/ https://ncbi.nlm.nih.gov/pubmed/21519488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4250/jcu.2011.19.1.21 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|